IHL-675A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IHL-675A, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis [Phase 2]